February 18, 2015 / 11:49 AM / 3 years ago

Actavis adjusted profit beats estimates

Feb 18 (Reuters) - Drugmaker Actavis Plc posted a better-than-expected adjusted quarterly profit, helped by higher sales of its branded drugs in North America.

The company’s net loss widened to $732.9 million, or $2.76 per share, in the fourth quarter ended Dec. 31 from $148.4 million, or 86 cents per share, a year earlier.

However, on an adjusted basis the company earned $3.91 per share. Analysts on average had expected $3.67, according to Thomson Reuters I/B/E/S.

Net revenue rose 46 percent to $4.06 billion. Total North American brands revenue nearly tripled to $1.83 billion. (Reporting by Vidya L Nathan in Bengaluru; Editing by Saumyadeb Chakrabarty)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below